9
million , up from $43.24 per diluted share
related to non-capitalized merger costs and plant consolidations .4 million in
2003, reflecting the transactions discussed above. EBITDA and
Adjusted EBITDA reflect additional ways of viewing HealthTronics'
operations that HealthTronics believes, when viewed with its GAAP
results and the reconciliations to the corresponding GAAP financial
measures, provide a more complete understanding of factors and trends
affecting HealthTronics' business than could be obtained absent this
disclosure. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

December 31, December 31,
($ in thousands) 2004 2003
------------ ------------
ASSETS

Total current assets $115,573 $69,110

Property and equipment, net 42,343 23,956

Assets of entities held for sale 6,472 --

Other assets 313,486 186,902
------------ ------------
$477,874 $279,968
============ ============
LIABILITIES

Total current liabilities $82,385 $35,266

Long-term debt, net of current portion 112,968 111,728

Other long-term liabilities 29,406 19,286
------------ ------------

Total liabilities 224,759 166,280

Liabilities of entities held for sale 6,351 --

Minority interest 29,277 7,077

Total stockholders' equity 217,487 106,611
------------ ------------
$477,874 $279,968
============ ============

HealthTronics Inc. NTEEP's largest customers include Sony
Ericsson Mobile Communications AB, Texas Instruments Incorporated, Sony
Computer Entertainment Europe Ltd.) Co.4 13.2 13.

q bostan

Business Editors/Health/Medical Writers

AUSTIN, Texas----HealthTronics Inc.13 per diluted share
in the fourth quarter of 2003.3 million or $0. Weighted average shares outstanding increased to 27.36 per diluted share for
the year ended December 31, 2003.
"Lithotripsy revenue per case remained steady at $2,067 in
partnership-driven cases, with an overall average of $1,920 per case
when including fee-for-service procedures. The proceeds of the debt will be used to refinance the existing
$100 million of legacy Prime 2008 8 3 /4% debentures and $33 million of
Senior Revolving debt. #3228653).healthtronics.

About HealthTronics Inc."

About NTEEP
Nam Tai Electronic + Electrical Products Limited ("NTEEP"), a subsidiary
of Nam Tai Electronics, Inc.
For more information about NTEEP, please visit its websites at
http://www.

Nam Tai Electronic + Electrical Products Limited
2005 Q4 Results Key Highlights

(In thousands of US Dollars, except as otherwise stated)

Quarterly Results 6 Months Results
4Q 2005 4Q 2004 YoY (%) 2H 2005 2H 2004 YoY (%)
Sales (Revenue) 40,731 42,189 (3.0
Profit from
Operations 3,388 5,519 (38.5
Per share
(US cent(s) ) 0.9) 1.0)
Diluted earnings
per share
(US cent(s)) 0.5
Profit from Operations
21,453 22,485 (4. If there had not been the
acquisition of Namtek Group and the exchange gain, the net profits
for 4Q, 2H and full year 2005 would have been a drop of US$2,572K
(47 .
(c) The Company issued 81,670,588 shares for the acquisition of Namtek
Group on 17 May 2005 and its profit was included as from that day.

kulinariya evdarl

Please call in 10 minutes before the call
is scheduled to begin. HealthTronics does not
reflect minority interest expense when calculating EBITDA, however,
HealthTronics adjusts for minority interest expense and refers to this
measure as "Adjusted EBITDA.
Adjusted EBITDA is also widely used by HealthTronics management in the
annual budget process.36
======== ======== ======== ========
Weighted average shares
outstanding 27,917 17,306 22,201 17,367
======== ======== ======== ========

PRO FORMA RESULTS
--------- --------
Income(loss) from continuing
operations, as reported $(3,908) $2,299 $793 $6,223
Compensation charge for employee
puts and stock buybacks,
net of tax -- -- (517) 944
Other 301 -- 301 180
Costs related to Mergers 1,663 -- 2,471 --
Costs related to Project
Waterford-plant consolidations 4,601 -- 6,410 --
-------- -------- -------- --------
Income(loss) from continuing
operations, pro forma $2,657 $2,299 $9,458 $7,347
======== ======== ======== ========
Diluted earnings per share:
Income(loss) from continuing
operations, pro forma $0.43 $0. Operating Profit down 38. Despite the tough market condition, we are conservatively
confident about the future prospect of the Group and believe that the Company
will continue to maintain sales growth in future and should be able to
generate fairly good return to its shareholders. Currently, NTEEP focuses on four segments of the
consumer electronics and communications sectors including optical devices,
home entertainment devices, mobile phone accessories and educational products.0)
(Note a)
% of sales 8.1)

Net profit 22,138 1,957 20,181 22,750 (11.

kulinariya m

Under
GAAP , loss from continuing operations for the fourth quarter of 2004
was $(3.
Excluding these charges , income from continuing operations in the
fourth quarter of 2004 would have been $2. Under GAAP, income
from continuing operations for 2004 was $0.9 million in Q-4 and $1.48-$0. Non-GAAP financial measures should not be considered as a
substitute for, or superior to, measures of financial performance
prepared in accordance with GAAP.

HEALTHTRONICS INC.
Net profit from the core business of the Group declined by approximately
47.6)
Gross Profit 6,286 1,034 5,252 8,548 (38.3)
Exchange gain on RMB
reserve 854 -- N/A

Adjusted net profit 19,327 22,750 (15.0)

2nd Half Year Results
2H/2005 2H/04
US$'000 NTEEP Namtek NTEEP NTEEP YoY
(including (excluding (%)
Namtek) Namtek)

Net Sales 85,643 2,837 82,806 88,790 (6.7)
(Revenue )
Gross Profit 16,436 2,347 14,089 17,750 (20.

h v

(NASDAQ:HTRN) today announced its financial results for the fourth
quarter and fiscal year ended December 31, 2004.2 million for 2004 from 17.
HealthTronics' President + CEO, Brad A. On a combined basis, and reported as
consolidated, Prime and HSS conducted 63,809 urology procedures during
2004 compared to 51 ,536 procedures for 2003.2% within
the legacy HSS partnerships were complemented by procedures conducted
within the Medstone complex, which was acquired by Prime in March
2004. Included in the 2004 total are 832 cryotherapy
treatments, representing an increase of 647 cases over the prior
year.
"In preparation for market, the Company sought and received
ratings on this anticipated debt transaction . HealthTronics strongly encourages investors to review its
financial information in its entirety and not to rely on a single
financial measure. For more information, visit
www.healthtronics.
Mr. Nonetheless, the management believes that there will be
more business opportunities based on the global trend of outsourcing by owners
of consumer electronics and communications products .5)
Gross Profit 6,286 8,548 (26.2 20.5 13.

q miri

("Prime") and only two
months of operations for legacy HealthTronics Surgical Services Inc.
("HSS") since the merger was declared effective on November 9, 2004.
"Our management team believes these steps, among others, will
allow us to direct resources toward our core businesses with the
prospect of higher rates of return and to those where we can exert a
necessary and appropriate degree of operating and financial control .5% within the legacy Prime partnerships and 5. 2004 division revenues grew 6% from the prior year to $105
million, largely due to strengthening demand for the mobile medical
product. In connection with completing this
process, we reorganized our division management and culled backlog of
commitments based on revised cost structure and resources, which
resulted in a write-down of inventory for projects that would be
unprofitable."

ORTHOPAEDICS SEGMENT

"As previously indicated, the Company has elected to position its
Orthopaedics business unit for sale."

REFINANCING

John Q.S.7% respectively mainly because of
the drop in gross profit as a result of the adoption of a competitive pricing
policy in pursuing orders for new products from existing as well as new
customers.6) 10,632 11,947 (11.21 1.8 13.60 2.5)
Diluted earnings per
share (US cent(s)) 2.

v h

"

SEGMENT ANALYSIS

UROLOGY
Q-1 Q-2 Q-3(b) Q-4(b)
------- - ------ ---------- ----------
2004 2004 2004 2004(c)

Procedures 7,249 8,703 9,215 13,643
Clicks 2,547 5,398 5,338 3,809
Revenue(a) 16,219 19,767 20,003 31,069
EBITDA(a) 9,257 11,012 11,939 17,434
Minority Interest (4,891) (5,373) (6,592) (10,232)
Adjusted EBITDA(a) 4,366 5,639 5,347 7,202

(a) Includes Medical Device Sales + Service. On a combined basis , and reported as consolidated, Prime
and HSS conducted 4,858 procedures during 2004, compared to 3,359 in
the prior year.
"Given the improved fundamentals and enhanced flexibility, the
Company has initiated the marketing of a $50 million Revolving Credit
Facility, due 2010, and a $125 million Senior Secured Term Loan B, due
2011. Management uses these non-GAAP financial measures internally
to evaluate its performance.13 $0. Therefore, the Group
will continue to expand the customer portfolio and develop a more diversified
range of products. which is listed on the New York Stock Exchange,
is a well-established vertically integrated manufacturing solutions provider
for some of the world's most reputable brand owners of consumer electronics
and communications products.
Nam Tai Electronics, Inc.8) 10,694 11,550 (7.4)
% of sales 8.0 12.0
Basic earnings
per share
(US cent(s)) 0.0
Gross Profit 33,582 3,093 30,489 33,536 (9.

azerbaijani stehlak

This GAAP loss from continuing
operations includes charges of $6.9 million
in the current fourth quarter from 17.8 million or $0.43 per diluted share, compared to $7. To
that end, the Company declared its intention to no longer fund or
support the operation of its Swiss subsidiary, HMT-AG.

"Fourth quarter and year-end results from the Company's Specialty
Vehicle unit reflect a generally steady-to-improving market for our
medical and broadcast products, as well as recent efforts to
reposition our product line in the Command + Control/Homeland Security
area. The conference call will also be webcast live
via the Investors section of the Company's web site at
www. generally accepted
accounting principles (GAAP).

HealthTronics provides healthcare services, primarily to the
urology community, and manufactures medical devices as well as
specialty vehicles used for the transport of high technology medical
and broadcast + communications equipment. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS/INFORMATION
GAAP VS.13 $0.04 $0.
Manufacturing Segment
Reconciliation of EBITDA and Adjusted EBITDA
Unaudited
(000's)

2004
----------------------------------- -----
1st Qtr 2nd Qtr 3rd Qtr 4th Qtr
--------- --------- --------- ----------
Revenues $23,757 $30,513 $26,192 $24,620

Expenses (22,348) (28,492) (24,066) (29,012)

Add Back:
Costs related to merger and
plant consolidation -- -- 1,325 6,536
FAS 150 charges 321 494 -- --
--------- --------- --------- ----------

EBITDA $1,730 $2,515 $3,451 $2,144
========= ========= ========= ==========

Through the recent acquisition of Namtek Software Development Company Limited
from its parent company, NTEEP extended its vertically integrated
manufacturing solution to include software development specializing in digital
dictionary and car navigation system.5) 16,436 17,750 (7.20 1.68 (42.6) 1.1 20.

nd ail

9) million or $(0.
These actions further our confidence in being able to achieve our
earlier stated target of $10 million in annualized cost savings. However, the resources required to fully develop this
market would detract from our focused efforts to improve our core
business lines and efficiently integrate these two companies. Accordingly , we are confirming our 2005 guidance
for revenues of $300-$310 million, adjusted EBITDA of $50-$51 million
and EPS of $0. Although HealthTronics believes that the
expectations reflected in such forward-looking statements are
reasonable, no assurance can be given that the expectations will prove
to be correct.5) 85,643 88,790 (3.44 (16.39 0.7)
% of sales 13.60 2.6)
Profit from
Operations 10,632 1,569 9,063 11,947 (24.

t evdarl

Initial Reporting Period for `New' HealthTronics; Strong Uro Group Performance; Integration on Schedule

"While we have operated as a combined company for only a few
months , our integration planning efforts have allowed us to move
quickly to confirm the Company's focus and proceed with our plan to
achieve the savings we identified while preparing for the merger.3
million in Q-3 relating to plant closings and consolidations. Procedures in this segment
decreased 3. Barnidge, HealthTronics' Chief Financial Officer,
commented, "Beyond the strategic possibilities and operating
efficiencies that the HealthTronics/Prime merger promises, the "new"
HealthTronics emerges significantly strengthened from a financial
standpoint. Standard + Poor's assigned a
BB -senior debt rating and "3" recovery rating to the proposed $50/$125
million facility."

Conference Call and Webcast

Management of HealthTronics will host a conference call the
morning of Wednesday , March 2, 2005 at 10:30 a.
Earnings before interest, taxes, depreciation and amortization
("EBITDA ") is a commonly used measure of performance which
HealthTronics believes, when considered with measures calculated in
accordance with GAAP, gives investors a more complete understanding of
HealthTronics ' operating results before the impact of investing and
financing transactions and income taxes.
During the quarter ended December 31, 2005, the Company recorded sales of
US$40.com .com .4)
% of sales 15.81 (10.3)
Net Profit (Note a) 22,138 22,750 (2.6)
Profit from Operations
3,388 507 2,881 5,519 (47.5)

(b) Assuming that the Group Re-organisation and the Capitalisation Issue
(details of which are disclosed in Appendix V to the Prospectus ) had
become effective on 1 January 2004.

nd ba

In accordance with generally accepted accounting principles
(GAAP), the financial results reported herein reflect a full year (12
months) for legacy Prime Medical Services Inc.13 per diluted share in
the same 2003 quarter (see GAAP reconciliation table and commentary
below).3 million in the same period a
year ago, reflecting shares issued for the acquisition of Medstone
International Inc.
Excluding these charges, income from continuing operations would have
been $9.5 million or $0.42 per diluted share in 2003.
"We will, of course , maintain our managerial commitments to our
partnerships and continue to provide maintenance, parts and
consumables to the installed base until a sale is consummated.

EBITDA AND ADJUSTED EBITDA

HealthTronics has presented EBITDA and Adjusted EBITDA amounts,
which are non-GAAP financial measures, in various filings with the
SEC.
HealthTronics believes that its presentations of EBITDA and Adjusted
EBITDA are important supplemental measures of operating performance to
its investors ." HealthTronics has historically reported
this measure to its investors and believes that the continued
inclusion of Adjusted EBITDA provides consistency in its financial
reporting. 13 /Xinhua-PRNewswire / -- Nam Tai Electronic and
Electrical Products Limited ("NTEEP" or "the Company") (Stock code: 2633 ), the
leading vertically-integrated manufacturing solutions provider of consumer
electronics and communications products, today announced its unaudited
consolidated results for the fourth quarter of 2005 and audited consolidated
results for the year ended December 31, 2005.1 12 .68 (42.5)
Weighted average
number of shares ('000) 851,240 800,000
Basic (Note b + c)
Diluted (Note b + c)

Notes:

(a) There had been meaningful contribution from Namtek Software
Development Company Limited and its subsidiaries ("Namtek Group")
since the completion of the acquisition thereof on 17 May 2005.0%), US $3,182K (27.com.

k v

Total revenues for the fourth quarter of 2004 rose 30% to $55.10 per
diluted share , compared to $2.7 million or $0. Additionally,
we will report the Company's Orthopaedics unit as income (loss) from
discontinued operations and assets held for sale.
"The Company continues to advance its prostate therapies
initiatives."

SPECIALTY VEHICLE MANUFACTURING SEGMENT

Q-1 Q-2 Q-3 Q-4 Q-4
--------- --------- --------- --------- ---------
2004 2004 2004 2004 2003

Units Delivered
Medical 26 34 31 43 38
Command/Homeland
Security 20 29 22 8 26
Broadcast 32 38 43 35 44
---- ----- --------- --------- --------- ---------
78 101 96 86 108
========= ========= ========= ========= =========

Revenue $23,757 $30,513 $26,192(a) $24,620(a) $28,175
EBITDA $1,730 $2,515 $3,451(a) $2,144(a) $3,576

(a) Excludes certain charges totaling $6. Sales of new broadcast vehicles grew 12%, but were offset by
a significant decrease in demand for remanufactured broadcast
vehicles.m. EST. In addition, the Company
has historically reported similar non-GAAP financial measures to its
investors and believes that the inclusion of comparative numbers
provides consistency in its financial reporting. Adjusted EBITDA is among the more significant factors in
management's internal evaluation of total company performance.7 million, representing a drop of 3.69 (44.52 2.9
Basic earnings per share
(US cent(s)) 2.5%) and US $3,423K (15.1)
Profit from Operations
21,453 2,144 19 ,309 22,485 (14.

lumat ba

See attached tables.6 million or $0.
Total revenues for the year ended December 31, 2004 rose 20% to
$193.1 million, up from $160.04 per
diluted share, down from $6. We anticipate completion of this refinancing on or
about April 1, 2005.com. A
telephone replay will be available for two weeks by dialing
800-642-1687 (706-645-9291 for international callers) and entering the
conference I. #3228653

HEALTHTRONICS' USE OF NON-GAAP FINANCIAL MEASURES

This press release includes financial measures for net income and
related per share amounts that exclude certain charges and therefore
have not been calculated in accordance with U. Investors are
encouraged to review the reconciliation of the non-GAAP financial
measures used in this press release to their most directly comparable
GAAP financial measure as provided with the financial statements
attached to this press release. PRO FORMA RESULTS
(includes 12 months of Prime and 2 months of HSS)
(Unaudited)

GAAP RESULTS Three Months
----- ------- Ended Year Ended
December 31, December 31,
($ in thousands, except
per share data) 2004 2003 2004 2003
-------- -------- -------- ------- -
Revenue:
Urology $31,069 $14,661 $87,058 $60,416
Manufacturing 24,620 28,175 105,082 98,955
Other 224 237 936 1,022
-------- -------- -------- ------- -
Total revenue 55,913 43,073 193,076 160,393
-------- -------- -------- --------
Cost of services and general and
administrative expenses:
Urology 15,454 5,859 40,315 24,816
Manufacturing 28,953 24,601 102,239 89,524
Corporate 2,187 1,160 4,911 3,574
Depreciation and amortization 2,642 1,653 7,946 7,063
-------- -------- -------- --------
49,236 33,273 155,411 124,977
-------- ----- --- -------- --------
Operating income 6,677 9,800 37,665 35,416
Other income (expenses):
Interest and dividends 121 48 328 313
Interest expense (2,744) (2,116) (9,778) (8,991)
Loan fees -- -- -- (257)
-------- -------- -------- --------
(2,623) (2,068) (9,450) (8,935)
-------- -------- -------- --------
Income before provision for income
taxes and minority interests 4,054 7,732 28,215 26,481
Minority interest in consolidated
income 10,232 4,788 27,088 17,591
-------- -------- -------- --------
Income(loss) from continuing (6,178) 2,944 1,127 8,890
operations before income taxes
Provision for income taxes (2,270) 645 334 2,667
-------- -------- -------- --------
Income(loss) from continuing
operations (3,908) 2,299 793 6 ,223
======== ======== ======== ========
Diluted earnings per share:
Income(loss) from continuing
operations $(0.14) $0.
Urology Segment
Reconciliation of EBITDA and Adjusted EBITDA
Unaudited
(000's)

2004
--------------------------- -------------
1st Qtr 2nd Qtr 3rd Qtr 4th Qtr(a)
--------- --------- --------- ----------
Revenues $16,219 $19,767 $20,003 $31,069

Expenses (6,962) (8,755) (9,057) (15,534)

Add Back:
Medstone Facility Close -- -- 993 600
Non-capitalized merger costs -- -- -- 1,299

EBITDA 9,257 11,012 11,939 17,434

Minority Interest Expense (4,891) (5,373 ) (6,592) (10,232)
--------- --------- --------- ----------

Adjusted EBITDA $4,366 $5,639 $5,347 $7,202
========= ========= ========= ==========

(a) Includes 3 months of Prime and 2 months of HSS

HealthTronics Inc. and
Canon Electronic Business Machines (H.K. It manufactures high -quality telecommunications products,
palm-sized PCs, personal digital assistants, linguistic products , calculators
and components such as LCD modules, wireless communication terminals and their
modules .6) 1.6)
(Note a)
% of sales 12.7
Per share (US cent (s)) 2.0)

12 Month Results
2005 2004
US$'000 NTEEP Namtek NTEEP NTEEP YoY
(including (excluding (%)
Namtek) Namtek)

Net Sales (Revenue) 167,339 3,695 163,644 163,584 0.

bostan q

and the merger between HSS and Prime.0
million in Q-3 relating to non-capitalized merger costs and
closing of Medstone facility.

If you are unable to listen live, the
conference call will be archived on the Company's web site .
EBITDA and Adjusted EBITDA are used in addition to and in
conjunction with results presented in accordance with GAAP. EBITDA and
Adjusted EBITDA should not be considered as an alternative to net
income, operating income, a liquidity measure, or any other operating
performance measure prescribed by GAAP, nor should these measures be
relied upon to the exclusion of GAAP financial measures .com

Statements by the Company's management during the conference call
announced in this press release that are not strictly historical,
including statements regarding plans, objective and future financial
performance, are "forward-looking" statements that are made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Factors that could cause actual results to differ
materially from HealthTronics' expectations include, among others, the
existence of demand for and acceptance of HealthTronics' services, the
integration of Prime's and HealthTronics ' businesses, regulatory
approvals, economic conditions, the impact of competition and pricing,
financing efforts and other factors described from time to time in
HealthTronics' periodic filings with the Securities and Exchange
Commission.42
======== ======== ======== ========
Weighted average shares
outstanding 27,917 17,306 22,201 17,367
======== ======== ======== ========

HEALTHTRONICS INC.6%
Final Dividend 0.3 million, almost flat as
compared to last year.6%
respectively when compared to the same period last year whilst net profit for
4Q and full year 2005 dropped by 36.8% and 2.3 13.5 13.84 (8. In
addition , an exchange gain on the RMB assets of the Company and its
subsidiaries (the "Group") as a result of the appreciation of RMB
was recorded in August this year.1)
Exchange gain on RMB
reserve 104 -- N/A

Adjusted net profit 2,895 5,467 (47.

azerbaijani miri

3 million or $0.7 million or $0. Barnidge continued, "Our post-merger integration plan is
progressing on schedule and we remain highly confident in achieving
our previously stated synergy target of $10 million of annualized
expense reductions.10 $0.

NTEEP Announces 2005 Q4 Results

45 US cent

HONG KONG, Feb.6% and 4 .namtai.5)
Net Profit
(Note a) 3,455 5,467 (36.84 (8.8)
Exchange gain on RMB
reserve 896 -- N /A

Adjusted net profit 8,368 11,550 (27.

world ba

2 million or $0. 2004 GAAP income from continuing
operations includes charges of $8.39 per diluted share
related to non-capitalized merger costs and plant consolidations.3 million
or $0.

(c) Includes three months of Prime and two months of HSS

"We remain encouraged by the trends and consistency exhibited
within our Urology group.
"Most of our attention during the fourth quarter was focused on
completing Project Waterford by closing our plants in Carlisle,
Pennsylvania and Sanford, Florida."

INTEGRATION + GUIDANCE

Mr. To participate
in the live call, please dial 888-743-0342 (706-679-0861 for
international callers) and ask for the "HealthTronics" call
(conference I. Non-GAAP net income and earnings per
share exclude certain charges in 2004 related to non-capitalized
merger costs , the closing of a newly acquired Medstone facility and
costs related to plant consolidations at HealthTronics ' Specialty
Vehicle division and for 2003, expenses primarily associated with the
implementation of FAS 150, Accounting for Certain Financial
Instruments with Characteristics of both Liabilities and Equity,
(collectively "Certain Charges").6%; EPS down 42.
Profit from operations for 4Q and full year 2005 dropped by 38.3
Gross Profit 33,582 33,536 0.1
% of sales 20.0%):

Quarterly Results
4Q/2005 4Q/04
US$'000 NTEEP Namtek NTEEP NTEEP YoY
(including (excluding (%)
Namtek ) Namtek)

Net Sales (Revenue) 40,731 1,322 39,409 42,189 (6.8)

Net profit 3,455 456 2,999 5,467 (45.

ail lumat

1 million in the same quarter of last year. Solid-same store
increases of 2.
"We believe the command segment is now well positioned to
profitably participate in this growing market, complementing the
growth we are projecting in our medical and broadcast units.5% from 2003 to 2004, as the payor community has been slow
to affirm reimbursement of the procedure.D. To listen to the live webcast, go to the web
site at least 10 minutes early to register, download and install any
necessary audio software . These non-GAAP financial measures
may be different from non-GAAP financial measures used by other
companies. By excluding Certain Charges, these
non-GAAP financial measures facilitate management 's internal
comparisons to the Company's historical operating results, to
competitors' operating results, and to estimates made by securities
analysts. In the SEC filings, HealthTronics has reconciled such amounts to
their most directly comparable financial measure calculated in
accordance with GAAP, which is HealthTronics' net income.5% when compared to the same period
last year whereas full year 2005 sales was US$167. ("NTE") (New York Stock Exchange symbol: NTE) is
an electronics design and manufacturing service provider to many of the
world's leading original equipment manufacturers , including Canon, Epson,
Optrex, Seiko Instruments, Sharp, Sony, Sony Ericsson, Texas Instruments ,
Toshiba and others.namtaieep. For more information about NTE, please visit its website
at http: //www.39 0.21 1.1)

Net profit 10,694 1,430 9,264 11,550 (19.

For more information, please contact:

Joyce Lam
Tel: +852 -2263-1014
Fax: +852-2263-1223
Email: joycelam@namtai.hk

world yat

4 million last year. Hummel, commented,
"Looking beyond the impact of costs related to our merger and plant
closures within our Specialty Vehicle unit, as well as the unusual
reporting method (12 months of Prime operations and two months of
HSS), fourth quarter and year-end performance was in line with our
expectations .5 million in Q-4 and $1.52.D. HealthTronics believes these measures continue
to be used by investors and creditors in their assessment of
HealthTronics' operating performance and the valuation of the company.0% if the contribution of the newly acquired software business and exchange
gain on RMB assets as a result of the appreciation of RMB this year had been
excluded., GN Netcom A/B, Seiko Instruments Inc. Ltd.38 0.

miri m

14) per diluted share, compared to income
from continuing operations of $2. Weighted average shares
outstanding increased to 22.

(b) Excludes certain charges totaling $1. We continue to believe our
infrastructure, installed base, and the clinical benefits of a
physician-directed , high energy product have a distinct advantage in
the marketplace. Moody's assigned a Ba3
rating to the proposed $175 million secured debt and upgraded its
senior implied rating to Ba3 from Ba.

The Company believes these non-GAAP
financial measures are useful to investors in allowing for greater
transparency of supplemental information used by management in its
financial and operational decision -making. Joseph Hsu, Chief Financial Officer of NTEEP, said, "Looking ahead, it
is expected that the competitive market condition faced by the Group in 2005
will repeat in 2006.4 20.3 19.49 (19.44 (16.0)

Weighted average
number of shares
('000) 881,671 800,000 881,671 800,000
Basic
(Note b + c)
Diluted
(Note b + c)

12 months Results
2005 2004 YoY (%)
Sales (Revenue) 167,339 163,584 2.